+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Cervical Cancer - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast - 2034

  • Report
  • March 2024
  • 112 Pages
  • Global
From
From
HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 180 Pages
  • Global
From
2X-121 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

2X-121 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
AZD-1775 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

AZD-1775 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
From
From
Aminopeptidase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Aminopeptidase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
TRAIL receptor 2 agonists - Pipeline Insight, 2024 - Product Thumbnail Image

TRAIL receptor 2 agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
ERBB 2 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

ERBB 2 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
CD33 antigen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

CD33 antigen inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Notch receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Notch receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Discoidin domain receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Discoidin domain receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
LAG-3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
AXL Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

AXL Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
P53 Antigen Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

P53 Antigen Modulators - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
TIGIT inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TIGIT inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CD47 antigen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

CD47 antigen inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more